1. Malaysia Stocks

  2. •

    Producer manufacturing

  3. •

    Miscellaneous manufacturing
Hextar Healthcare Bhd

Hextar Healthcare Bhd

MMYX:HEXCARE
0.06
MYR
0.00
(0.00%)
Nov 26Next Earn
Hextar Healthcare Bhd
MYX:HEXCARE
(Bursa Malaysia)

Recent

price

0.06

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
MYR
0.57
0.62
0.59
0.47
0.43
0.44
0.45
0.26
0.27
0.29
0.52
0.6
0.2
0.15
0.14
0.13
0.12
Revenue per Share
0.01
0.01
0.03
- -
0.01
0.02
0.03
0.02
-0.07
0.04
0.16
0.22
-0.06
-0.06
-0.01
-0.04
-0.05
Basic EPS, GAAP
0.04
0.03
0.04
0.06
0.04
-0.04
- -
0.04
0.03
0.01
0.1
0.1
-0.04
-0.03
-0.02
0.01
- -
Free Cash Flow per Basic Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
- -
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.25
0.28
0.26
0.29
0.3
0.36
0.37
0.37
0.28
0.27
0.45
0.69
0.6
0.54
0.46
0.41
0.39
Book Value per Share
0.24
0.27
0.24
0.26
0.28
0.33
0.34
0.34
0.27
0.26
0.45
0.67
0.59
0.53
0.45
0.41
0.39
Tangible Book Value per Share
605
606
638
696
682
683
688
734
757
757
803
852
895
1,002
1,045
1,102
1,102
Basic Weighted Avg Shares
343
374
377
325
296
300
311
188
205
219
415
510
175
155
147
148
133
Sales/Revenue/Turnover
7.33
5.54
8.86
3.08
8.37
8.42
7.19
10.82
5.55
9.27
39.35
16.9
19.56
-42.57
-15.36
-14.68
-17.88
Operating Margin (%)
17
16
15
16
17
20
23
25
24
8
9
13
15
20
17
15
- -
Depreciation Expense
7
8
22
- -
10
15
21
13
-52
27
131
186
-56
-64
-14
-45
-50
Net Income, GAAP
19.65
26.88
14.98
90.45
38.74
26.63
21.07
13.21
14.36
27.89
18.54
21.56
- -
- -
- -
- -
- -
Effective Tax Rate (%)
1.92
2.27
5.85
0.13
3.42
4.96
6.71
7.01
-25.38
12.12
31.6
36.42
-31.83
-41.6
-9.47
-30.04
-37.47
Profit Margin (%)
10
43
63
62
66
65
64
90
131
75
199
393
205
154
127
110
97
Working Capital
11
29
25
16
18
40
36
25
13
1
5
1
3
4
2
- -
- -
LT Debt
151
167
180
195
206
246
252
277
214
205
378
601
605
542
508
452
435
Total Equity
8.24
5.4
10.09
0.36
5.69
6.14
5.31
5.21
3.24
6.11
43.63
13.59
- -
- -
- -
- -
- -
Return on Invested Capital (%)
4.9
5.42
10
0.34
4.65
5.75
6.94
4.77
-16.56
11.69
43.63
37.64
- -
- -
- -
- -
- -
Return on Capital (%)
4.29
5.35
12.67
0.22
5.06
6.59
8.39
4.99
-21.21
12.64
45.02
37.95
-9.24
-11.23
-2.65
-9.27
-10.74
Return on Common Equity (%)

Capital Structure

MYR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,102
1,102
1,102
Market Capitalization
105
99
66

Working Capital

MYR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
133
130
126
Cash, Cash Equivalents & STI
24
32
27
Accounts Receivable, Net
20
14
18
Inventories
44
44
45
Total Current Liabilities
23
22
29
Payables & Accruals
- -
- -
- -
ST Debt
2
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.17%
6.44%
-10.95%
Free Cash Flow
-162.32%
-64.84%
-155.58%
Net Income, GAAP
-17.97%
13.71%
219.69%
Sales/Revenue/Turnover
1.1%
-11.73%
0.79%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
40
35
30
42
147
2025
38
39
36
36
148
2026
31
30
- -
- -
- -

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-0.01
-0.01
2025
- -
- -
-0.01
-0.03
-0.04
2026
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Astral Limited (NSE:ASTRAL)
Supreme Industries Limited (NSE:SUPREMEIND)
V.S. Industry Bhd. (MYX:VS)
Izmir Firca Sanayi ve Ticaret AS (BIST:IZFAS)
Kuzey Boru A.S. (BIST:KBORU)
Isik Plastik Sanayi VE Dis Ticaret Pazarlama AS (BIST:ISKPL)
Business
Hextar Healthcare Berhad is a Malaysian investment holding company principally engaged in the manufacturing, distribution and trading of natural rubber, synthetic rubber and nitrile disposable gloves for household, industrial, professional and food handling applications; and the production of in-vitro diagnostics (IVD) medical devices including rapid test kits and enzyme-linked immunosorbent assay test kits for detection and diagnosis of infectious diseases and drug-of-abuse screening for medical professionals and clinical diagnostic markets. The company also trades gloves, household and kitchen items, and personal protective products through its Gloves Operation, Medical Devices Operation, and Investment Holding segments, with additional involvement in property investment. Founded in 1987 and headquartered in Ipoh, Perak, Malaysia, with a 140,000 square meter production facility there and a dedicated office in Valencia, Spain, it exports to over 100 countries across Europe, North America, South America and the Asia Pacific. Formerly known as Rubberex Corporation (M) Berhad, it was incorporated in 1996, listed on the Main Market of Bursa Malaysia Securities Berhad in 1997 under ticker 7803.KL, changed its name to Hextar Healthcare Berhad effective September 29, 2022, and acquired Reszon Diagnostics International Sdn Bhd in 2022 to expand into healthcare diagnostics; in October 2021, it subscribed for a 20% equity interest in Alliance Empire Sdn Bhd for RM180 million to develop and operate Hextar World at Empire City Damansara Mall, a 1.8 million sq ft retail and lifestyle hub scheduled to open in 4Q 2025.